Krystal Biotech, Inc. (KRYS)
358.24
-13.23
(-3.56%)
USD |
NASDAQ |
Sep 04, 16:00
358.05
-0.19
(-0.05%)
After-Hours: 20:00
Krystal Biotech SG&A Expense (TTM) : 159.89M for June 30, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 159.89M |
| March 31, 2026 | 155.20M |
| December 31, 2025 | 146.91M |
| September 30, 2025 | 136.75M |
| June 30, 2025 | 127.88M |
| March 31, 2025 | 120.35M |
| December 31, 2024 | 113.68M |
| September 30, 2024 | 107.16M |
| June 30, 2024 | 102.14M |
| March 31, 2024 | 100.42M |
| December 31, 2023 | 98.40M |
| September 30, 2023 | 97.67M |
| June 30, 2023 | 93.90M |
| March 31, 2023 | 85.86M |
| December 31, 2022 | 77.74M |
| September 30, 2022 | 66.57M |
| June 30, 2022 | 56.21M |
| March 31, 2022 | 48.15M |
| December 31, 2021 | 40.39M |
| September 30, 2021 | 32.27M |
| June 30, 2021 | 27.28M |
| Date | Value |
|---|---|
| March 31, 2021 | 20.80M |
| December 31, 2020 | 15.06M |
| September 30, 2020 | 12.12M |
| June 30, 2020 | 8.998M |
| March 31, 2020 | 7.357M |
| December 31, 2019 | 6.463M |
| September 30, 2019 | 6.075M |
| June 30, 2019 | 5.676M |
| March 31, 2019 | 4.926M |
| December 31, 2018 | 4.156M |
| September 30, 2018 | 3.149M |
| June 30, 2018 | 2.829M |
| March 31, 2018 | 2.174M |
| December 31, 2017 | 1.563M |
| September 30, 2017 | 1.371M |
| June 30, 2017 | 0.714M |
| March 31, 2017 | 0.548M |
| December 31, 2016 | 0.402M |
| September 30, 2016 | 0.184M |
| June 30, 2016 | 0.103M |
| March 31, 2016 | 0.00 |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| TG Therapeutics, Inc. | 296.46M |
| Cytokinetics, Inc. | 370.47M |
| Marker Therapeutics, Inc. | 4.244M |
| Alnylam Pharmaceuticals, Inc. | 1.318B |
| Exelixis, Inc. | 533.92M |